483 Glenmark Pharmaceuticals Apr 2019

483 Glenmark Pharmaceuticals Apr 2019

Justin Boyd FDA, Rita Kabaso FDA$119.00 - Available Now

FDA investigators audited the Glenmark Pharmaceuticals - Solan, India facility and issued inspectional observations (via FDA 483) on 20 Apr 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Apr 2019
  • Location: Solan, India
  • FEI: 3005757050
Add To Cart